Share this:
Vaginal microbes point toward early detection and screening for endometrial cancer
Article by Colette Gallagher, Public Affairs
Marina Walther-Antonio, Ph.D., a researcher from the Mayo Clinic Center for Individualized Medicine, set out to discover the role microbiomes play in the development of endometrial cancer. Mayo researchers conducted the first direct assessment uterine microbiome study published in Genome Medicine.
As a result of the study, researchers now know that:
- The uterine microbiome of women with endometrial cancer is different from the uterine microbiome of women without endometrial cancer.
- The microbes present in the vaginal environment of women with endometrial cancer are also different from the microbes present in the vaginal environment of women without endometrial cancer.
Dr. Marina Walther-Antonio
“These findings provide important insights into the etiology or manifestation of the disease with broad implications for biomarker development in the early detection of, and screening for, endometrial cancer,” says Dr. Walther-Antonio.
Get the latest news from the Center for Individualized Medicine. Visit our blog, Facebook, LinkedIn or Twitter at @MayoClinicCIM.
You’ll want to save the date for the next Individualizing Medicine Conference. It is planned for Oct. 9-11, 2017.
Tags: #uterine microbiome, biomarker, center for individualized medicine, Dr. Marina Walther-Antonio, Endometrial cancer, mayo clinic, medical research, Uncategorized